January 26, 2018 / 3:20 PM / 7 months ago

BRIEF-Abbvie CEO To Discuss Dividend Growth, Share Buybacks With Board

Jan 26 (Reuters) - Abbvie Inc:

* ABBVIE SEES 2018 NON-GAAP U.S. TAX RATE OF 9 PERCENT GRADUALLY RISING TO 13 PERCENT OVER NEXT 5 YEARS; CORRECTS FROM GAAP

* ABBVIE SAYS PLANS TO FILE FOR VENCLEXTA APPROVAL IN AML LATER THIS YEAR

* ABBVIE SAYS VENCLEXTA AML APPROVAL COULD COME 2 YEARS AHEAD OF INITIAL EXPECTATIONS

* ABBVIE SEES Q1 ADJUSTED EPS $1.70 TO $1.79; OPERATING PERCENTAGE REVENUE GROWTH APPROACHING MID TEENS

* ABBVIE CEO SAYS LOOKING FOR ASSETS THAT CAN DRIVE STRONG GROWTH IN 2023-2025 TIME FRAME

* ABBVIE CEO SAYS TO DISCUSS ACCELERATION OF DIVIDEND GROWTH, SHARE BUYBACKS WITH BOARD Source text for Eikon: Further company coverage: (Reporting By Bill Berkrot)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below